FDA 483 - Bio-Medical Pharmaceutical Manufacturing Corporation - January 23, 2020

Bio Medical & Pharmaceutical Manufacturing Corp. in Houston, TX, was inspected regarding its drug product manufacturing operations. The inspection revealed significant deficiencies, including failure to follow written cleaning procedures, inadequate CGMP training for employees, and poor maintenance of equipment calibration records. These issues indicate a lack of adherence to current Good Manufacturing Practices.